Seizures in oligodendroglial tumors

作者: Melissa Kerkhof , Christa Benit , Alberto Duran-Pena , Charles J Vecht

DOI: 10.2217/CNS.15.29

关键词: GliomaAnesthesiaMedicineBrain tumorValproic AcidEpilepsyOligodendroglial TumorNeurosurgeryLevetiracetamInternal medicineOncologyRadiation therapy

摘要: Epilepsy develops in more than 70-90% of oligodendroglial tumors and represents a favorable indicator for long-term survival if present as the first clinical sign. Presence IDH1 mutation is frequently associated with seizures oligodendrogliomas, next to alterations glutamate GABA metabolism origin glioma-associated epilepsy. Treatment by surgery or radiotherapy results seizure freedom about two-thirds patients, chemotherapy reduction 50%. Symptomatic anticonvulsive therapy levetiracetam valproic acid monotherapy are both evidence-based drugs partial epilepsies, their effective use brain supported large amount additional data. Pharmacoresistance against anticonvulsants prevalent among occurring 40% despite polytherapy two more. Toxic signs involve cognition, bone marrow skin. Previous neurosurgery, radiation add risks cognitive dysfunction.

参考文章(93)
Jonathan H. Sherman, Krisztina Moldovan, H. Kwang Yeoh, Robert M. Starke, Nader Pouratian, Mark E. Shaffrey, David Schiff, Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. Journal of Neurosurgery. ,vol. 114, pp. 1617- 1621 ,(2011) , 10.3171/2010.12.JNS101602
Avanita S. Prabowo, Anand M. Iyer, Tim J. Veersema, Jasper J. Anink, Antoinette Y. N. Schouten-van Meeteren, Wim G. M. Spliet, Pieter C. van Rijen, Cyrille H. Ferrier, David Capper, Maria Thom, Eleonora Aronica, BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors. Brain Pathology. ,vol. 24, pp. 52- 66 ,(2014) , 10.1111/BPA.12081
Martin J. Brodie, Scott Mintzer, Alison M. Pack, Barry E. Gidal, Charles J. Vecht, Dieter Schmidt, Enzyme induction with antiepileptic drugs: Cause for concern? Epilepsia. ,vol. 54, pp. 11- 27 ,(2013) , 10.1111/J.1528-1167.2012.03671.X
Riccardo Soffietti, BG Baumert, L Bello, Andreas Von Deimling, H Duffau, M Frénay, W Grisold, R Grant, F Graus, Khe Hoang‐Xuan, M Klein, Beatrice Melin, J Rees, T Siegal, Anja Smits, Roger Stupp, Wolfgang Wick, None, Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force European Journal of Neurology. ,vol. 17, pp. 1124- 1133 ,(2010) , 10.1111/J.1468-1331.2010.03151.X
Pritesh N Bodalia, Anthony M Grosso, Reecha Sofat, Raymond J MacAllister, Liam Smeeth, Soraya Dhillon, Juan‐Pablo Casas, David Wonderling, Aroon D Hingorani, None, Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials. British Journal of Clinical Pharmacology. ,vol. 76, pp. 649- 667 ,(2013) , 10.1111/BCP.12083
Cordelia Luyken, Ingmar Blümcke, Rolf Fimmers, Horst Urbach, Christian E Elger, Otmar D Wiestler, Johannes Schramm, None, The Spectrum of Long-term Epilepsy-associated Tumors : Long-term Seizure and Tumor Outcome and Neurosurgical Aspects Epilepsia. ,vol. 44, pp. 822- 830 ,(2003) , 10.1046/J.1528-1157.2003.56102.X
Gashirai K Mbizvo, Pete Dixon, Jane L Hutton, Anthony G Marson, None, Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review Cochrane Database of Systematic Reviews. ,(2012) , 10.1002/14651858.CD001901.PUB2